{"id": "1364201327769739270", "creation": 1614085916.0, "user_id": "49616273", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 2, "like_count": 6, "quote_count": 0}}, "text": "Sinopharm plans to bring new recombinant sub-unit #COVID19 #vaccine to clinical trial, becoming 2nd frontrunner biotechnology developer after China's Zhifei Longcom Biopharmaceutical, which started late-stage trials in Pakistan upon approval on Sun. https://t.co/y41rykVgQ3", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}